Vafa Tabatabaie is an Endocrinology/Metabolic physician affiliated with Albert Einstein College of Medicine. OpenAlex indexes 40 publications with 586 citations (h-index 11); ClinicalTrials.gov lists 1 registered study matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Clinical trials
- Compassionate Use of SOM230 for Hyperinsulinemic/Hypoglycemia
Sponsor: Montefiore Medical Center
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
2 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- LEO Pharma Inc.Program year20251 payment
- Amgen Inc.Program year20252 payments
- Amgen Inc.Program year20241 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Hormonal (systemic)
58.3%l-Thyroxine39%Levothyroxine Sodium93%Synthroid8%Part D≥93 patientsParathyroid Hormone Analog8.3%Teriparatide73%Forteo27%Part D<11 patients+ 3 more classes in this area
Metabolism & gastrointestinal
24.8%GLP-1 receptor agonist10.5%Trulicity86%Ozempic14%Part D<11 patientsBiguanide (metformin)6.2%Metformin Hcl62%Metformin Hcl Er38%Part D<11 patients+ 4 more classes in this area
Musculoskeletal
10.7%Bisphosphonates7.2%Risedronate Sodium100%Part D≥18 patientsOther drugs affecting bone structure and mineralization2%Evenity (2 Syringes)100%Part D<11 patients+ 1 more class in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Obesity and healthy aging: fat, muscle, and bone trade-offs in an era of potent weight-loss pharmacotherapy
The Journals of Gerontology Series A
2026 - 8188 Pituitary hyperplasia resulting from primary hypothyroidism: A case report
Journal of the Endocrine Society
2024 - SAT258 Successful Treatment Of Adult T-cell Leukemia-lymphoma Induced Hypercalcemia With Denosumab
Journal of the Endocrine Society
2023 - SAT191 Primary Hyperparathyroidism With Low-Normal Parathyroid Hormone Levels: Phosphorus Can Be The Key
Journal of the Endocrine Society
2023
Similar KOLs
Other experts from the same institution or the same specialty.
Richard Lipton, MD
Albert Einstein College of Medicine
Marina Konopleva, MD, PhD
Albert Einstein College of Medicine
Jill Crandall, MD
Albert Einstein College of Medicine
Betsy Herold, MD
Albert Einstein College of Medicine
Yousef Saleh Khader
Jordan University of Science and Technology
Jens Juul Holst
University of Copenhagen
Victor Montori, MD
Mayo Clinic
Christos Mantzoros, MD
Harvard Medical School
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”